期刊文献+

复方奥硝唑甲磺酸培氟沙星缓释牙栓的缓释抑菌作用的评价 被引量:2

Evaluation of sustained-release bacteriostatic effect of compound ornidazole and pefloxacinmesylate sustained-release gum suppository
下载PDF
导出
摘要 目的观察复方奥硝唑甲磺酸培氟沙星缓释牙栓的缓释、抑菌作用。方法采用Kirby-Bauer纸片扩散法进行复方缓释牙栓的缓释、细菌敏感稳定性、基质影响试验。结果复方奥硝唑甲磺酸培氟沙星缓释牙栓对牙龈卟啉单胞菌等几个菌种有明显的缓释作用,缓释时间可达12h以上。将该牙栓4℃存放6个月后,仍有明显的抑菌作用,与半年前的抑菌环进行比较,无显著性差异(P>0.05)。但对于基质影响试验,加入基质组对金黄色葡萄球菌、牙龈卟啉单胞菌、具核梭杆菌、消化链球菌的抑菌作用相对减弱(P<0.05),而对表皮葡萄球菌、中间普氏菌、变形链球菌抑菌环无显著性差别(P>0.05)。结论复方奥硝唑甲磺酸培氟沙星缓释牙栓对牙周致病菌有明显的缓释、稳定的抑菌作用以及基质影响较小,稳定性较好。 Objective To observe the bacteriostatic effect of compound omidazole and pefloxacinmesylate sustained-release gum suppository. Methods The sustained-release, sensitive stability of bacteria, ground substance effect of the suppository were tested by using Kirby-Bauer paper dispersed method. Results gum suppository had significant bacteriostatic effect on Porphyromonsa gingivals and other bacteria. Th The e SUS- tained-release time was above 12 h. The gum suppository still had bacteriostatic effect after preserved for 6 months at 4℃, with no significant difference in compared with 6 months before. The ground substance effect test discovered that the bacteriostatic effect of adding ground substance group was weaker than that of no adding ground substance group to Staphylococcus aureus, Porphyromonsa gingivals, Fusobacterium nucleatum, Peptostreptococcus spp (P 〈 0.05), but the bacteriostatic effect was no significant different between adding ground substance group and no adding ground substance group to Staphylococcus epiderrnidis, Prevotells intermedia, and Streptococcus mutans. Conclusion Compound ornidazole and pelfloxacinmesylate sustained-release gum suppository had significant bacteriostatic effect, with delayed release, better stability, and no influence on the around substance.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2007年第3期261-263,共3页 Journal of Third Military Medical University
基金 重庆市科委基金(2004BB5065)~~
关键词 奥硝唑 甲磺酸培氟沙星 缓释 牙栓 抑菌作用 ornidazole pefoloxacinmesylate sustained-release gum suppository bacteriostasis
  • 相关文献

参考文献9

  • 1蒋艳,刘鲁川,李楠,段延华.奥硝唑牙栓的制备及质量控制[J].第三军医大学学报,2006,28(9):990-991. 被引量:12
  • 2Salari M H,Kadkhoda Z.Rate of cultivable subgingival periodontopathogenic bacteria in chronic periodontitis[J].J Oral Sci,2004,46(3):157-161.
  • 3Citron Dm,Kwok Y Y,Appleman M D.In vitro activity of oritavancin(LY333328),vancomycin,clindamycin,and metronidazole against Clostridium perfringens,Propionibacterium acnes,and anaerobic Gram-positive cocci[J].Anaerobe,2005,11(1-2):93-95.
  • 4Lamp K C,Freeman C D,Klutman N E,et al.Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials[J].Clin Pharmacokinet,1999,36(5):353-373.
  • 5段延华,刘鲁川,蒋艳,李楠,张莉,熊辉,孟德胜.奥硝唑和培氟沙星不同配伍对牙周病原菌体外抗菌作用[J].口腔医学研究,2006,22(2):162-165. 被引量:8
  • 6Trombelli L,Tatakis D N.Periodontal diseases:current and future indications for local antimicrobial therapy[J].Oral Dis,2003,9(Suppl 1):11-15.
  • 7Boxembaum H.Pharmacokinetic determinations in the design and evaluation of sustained-release dosage forus[J].Pharm Res,1984,1:82.
  • 8Banerjee P S,Robinson J R.Novel drug delivery systems.An overview of their impact in clinical pharmacokinetic studies[J].Clin Pharmacokinet,1991,20(1):1-20.
  • 9Byotra S P,Avasthi R,Irani P,et al.COMS (ciprofloxacin once daily monitored study) in acute exacerbation of chronic bronchitis[J].The Indian Practitioner,2002,55(1):16-20.

二级参考文献14

  • 1刘学聪,边百川,张玉.奥硝唑糊剂治疗牙周炎的近期疗效观察[J].现代中西医结合杂志,2004,13(15):2019-2019. 被引量:12
  • 2李从荣,金正江,詹,丁俊清,李艳,彭少华.奥硝唑治疗口腔厌氧菌感染的临床与实验研究[J].中华医院感染学杂志,2004,14(3):325-327. 被引量:40
  • 3Cennet Celik.In vitro activities of tinidazole and metronidazole against clostridium diffieile,prevotellabivia and bacteroides fragilis[J].Anaerobe,2005,4(17):101-103
  • 4周学东,肖晓蓉.口腔微生物学[M].四川大学出版社,2001,4(15):390-407
  • 5Socransky S,Haffajee A.Evidence of aetiology:a historical perspective[J].Periodontol,2000,1994(5):7-10
  • 6Zambon JJ.Periodontal diseases:microbial factors[J].An Periodontol,1996,1(12):879-883
  • 7Tyrrell KL.In vitro activity of oritavancin (LY333328),vancomycin,clindamycin,and metronidazole against Clostridium perfringens,Propionibacterium acnes,and anaerobic Gram-positive cocci[J].Anaerobe,2005,11(2):93-95
  • 8Kamma JJ,Nakou M,Mitsis FJ.The clinical and microbiological effects of systemic ornidazole in sites with and without subgingival debridement in early-onset periodontitis patients[J].Periodonto,2000,71(12):1 862-1 865
  • 9Sydney M.Antimicrobial susceptibilities of Bacteroides fragilis and Bacteroides thetaiotaomicron strains isolated from clinical specimens and human intestinal microbiota[J].Anaerobe,2004,10(5):255-259
  • 10TROMBELLI L,TATAKIS D N.Periodontal diseases:current and future indications for local antimicrobial therapy[J].Oral Dis,2003,9 (Suppl 1):11 -15.

共引文献16

同被引文献29

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部